Alpha-1-antitrypsin inhibits nitric oxide production

Journal of Leukocyte Biology

Volumn 92, Issue 6, 2012, Pages 1251-1260

  Chan, Edward D ^a,b   Pott, Gregory B ^c   Silkoff, Philip E ^b,e   Ralston, Annemarie H ^d   Bryan, Courtney L ^c   Shapiro, Leland ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d HOLLAND LABORATORY   (United States)

^e Janssen R and D of the J and J group of companies   (United States)

Author keywords

1 proteinase inhibitor; INOS; MAPK; NF B

Indexed keywords

ALPHA 1 ANTITRYPSIN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; SERINE PROTEINASE INHIBITOR;

ANIMAL CELL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENE TRANSLOCATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNTHESIS;

ALPHA 1-ANTITRYPSIN; ANIMALS; CELL LINE; ENZYME ACTIVATION; HUMANS; MACROPHAGES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION;

MURINAE;

EID: 84870404682     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0212071     Document Type: Article

References (69)

1. Fang, F. C. (1997) Mechanisms of nitric oxide-related antimicrobial activity. J. Clin. Invest. 100, S43-S50.
2. Nussler, A. K., Billiar, T. R. (1993) Inflammation, immunoregulation, and inducible nitric oxide synthase. J. Leukoc. Biol. 54, 171-178.
3. Vincent, J-L., Zhang, H., Szabo, C., Prieser, J-C. (2000) Effects of nitric oxide in septic shock. Am. J. Resp. Crit. Care Med. 161, 1781-1785.
4. Cobb, J. P., Danner, R. L. (1996) Nitric oxide and septic shock. JAMA 275, 1192-1196.
5. Kroncke, K. D., Fehsel, K., Kolb-Bachofen, V. (1998) Inducible nitric oxide synthase in human diseases. Clin. Exp. Immunol. 113, 147-156.
6. Bogdan, C. (2001) Nitric oxide and the immune response. Nat. Immunol. 2, 907-916.
7. Daubener, W., Schmidt, S. K., Heseler, K., Spekker, K. H., MacKenzie, C. R. (2009) Antimicrobial and immunoregulatory effector mechanisms in human endothelial cells. Indoleamine 2,3-dioxygenase versus inducible nitric oxide synthase. Thromb. Haemost. 102, 1110-1116.
8. Kobayashi, Y. (2010) The regulatory role of nitric oxide in proinflammatory cytokine expression during the induction and resolution of inflammation. J. Leukoc. Biol. 88, 1157-1162.
9. Woods, M. E., Olano, J. P. (2008) Host defenses to Rickettsia rickettsii infection contribute to increased microvascular permeability in human cerebral endothelial cells. J. Clin. Immunol. 28, 174-185.
10. Cox, G. W., Melillo, G., Chattopadhyay, U., Mullet, D., Fertel, R. H., Varesio, L. (1992) Tumor necrosis factor-α-dependent production of reactive nitrogen intermediates mediates IFN-γ plus IL-2-induced murine macrophage tumoricidal activity. J. Immunol. 149, 3290-3296.
11. Ding, A. H., Nathan, C. F., Stuehr, D. J. (1988) Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 141, 2407-2412.
12. Nathan, C. F., Xie, Q-W. (1994) Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269, 13725-13728.
13. Weitzberg, E., Hezel, M., Lundberg, J. O. (2010) Nitrate-nitrite-nitric oxide pathway: implications for anesthesiology and intensive care. Anesthesiology 113, 1460-1475.
14. Dinarello, C. A. (1996) Biologic basis for interleukin-1 in disease. Blood 87, 2095-2147.
15. Shapiro, L., Clark, B. D., Orencole, S. F., Poutsiaka, D. D., Granowitz, E. V., Dinarello, C. A. (1993) Detection of tumor necrosis factor soluble receptor p55 in blood samples from healthy and endotoxemic humans. J. Infect. Dis. 167, 1344-1350.
16. Leiper, J., Nandi, M. (2011) The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis. Nat. Rev. Drug Discov. 10, 277-291.
17. Anderstam, B., Katzarski, K., Bergstrom, J. (1997) Serum levels of NG, NG-dimethyl-l-arginine, a potential endogenous nitric oxide inhibitor in dialysis patients. J. Am. Soc. Nephrol. 8, 1437-1442.
18. Tumurkhuu, G., Koide, N., Hiwasa, T., Ookoshi, M., Dagvadorj, J., Abu Shadat Mohammod, N., Iftakhar, E. K. I., Naiki, Y., Komatsu, T., Yoshida, T., Yokochi, T. (2011) ONO 3403, a synthetic serine protease inhibitor, inhibits lipopolysaccharide-induced tumor necrosis factor-{α} and nitric oxide production and protects mice from lethal endotoxic shock. Innate Immun. 17, 97-105.
19. Jorens, P. G., Van Overeld, F. J., Bult, H., Vermiere, P. A., Herman, A. G. (1992) Serine-protease inhibitors modulate nitric oxide-synthase activity of alveolar macrophages. Agents Actions 36, 243-247.
20. Kim, H., Lee, H. S., Chang, K. T., Ko, T. H., Baek, K. J., Kwon, N. S. (1995) Chloromethyl ketones block induction of nitric oxide synthase in murine macrophages by preventing activation of nuclear factor-κ B. J. Immunol. 154, 4741-4748.
21. Blank, C. A., Brantly, M. (1994) Clinical features and molecular characteristics of α 1-antitrypsin deficiency. Ann. Allergy 72, 105-120.
22. American Thoracic Society, European Respiratory Society (2003) American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am. J. Respir. Crit. Care Med. 168, 818-900.
23. Brantly, M., Nukiwa, T., Crystal, R. G. (1988) Molecular basis of α-1-antitrypsin deficiency. Am. J. Med. 84, 13-31.
24. Brantly, M. L., Wittes, J. T., Vogelmeier, C. F., Hubbard, R. C., Fells, G. A., Crystal, R. G. (1991) Use of a highly purified α 1-antitrypsin standard to establish ranges for the common normal and deficient α 1-antitrypsin phenotypes. Chest 100, 703-708.
25. Scuderi, P., Dorr, R. T., Liddil, J. D., Finley, P. R., Meltzer, P., Raitano, A. B., Rybski, J. (1989) α-Globulins suppress human leukocyte tumor necrosis factor secretion. Eur. J. Immunol. 19, 939-942.
26. Janciauskiene, S., Larsson, S., Larsson, P., Virtala, R., Jansson, L., Stevens, T. (2004) Inhibition of lipopolysaccharide-mediated human monocyte activation, in vitro, by α1-antitrypsin. Biochem. Biophys. Res. Commun. 321, 592-600.
27. Janciauskiene, S. M., Nita, I. M., Stevens, T. (2007) α1-Antitrypsin, old dog, new tricks. α1-Antitrypsin exerts in vitro anti-inflammatory activity in human monocytes by elevating cAMP. J. Biol. Chem. 282, 8573-8582.
28. Nita, I., Hollander, C., Westin, U., Janciauskiene, S. M. (2005) Prolastin, a pharmaceutical preparation of purified human α1-antitrypsin, blocks endotoxin-mediated cytokine release. Respir. Res. 6, 12.
29. Pott, G. B., Chan, E. D., Dinarello, C. A., Shapiro, L. (2009) α-1-Antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood. J. Leukoc. Biol. 85, 886-895.
30. Shapiro, L., Pott, G. B., Ralston, A. H. (2001) α-1-Antitrypsin inhibits human immunodeficiency virus type-1. FASEB J. 15, 115-122.
31. Coeshott, C., Ohnemus, C., Pilyavskaya, A., Ross, S., Wieczorek, M., Kroona, H., Leimer, A. H., Cheronis, J. (1999) Converting enzyme-independent release of tumor necrosis factor α and IL-1β from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase-3. Proc. Natl. Acad. Sci. USA 96, 6261-6266.
32. Murphy, W. J., Muroi, M., Zhang, X., Suzuki, T., Russel, S. W. (1996) Both a basal and an enhancer IB element is required for full induction of the mouse inducible nitric oxide synthase gene. J. Endotoxin Res. 3, 381-393.
33. Chen, K., Popel, A. S. (2009) Nitric oxide production pathways in erythrocytes and plasma. Biorheology 46, 107-119.
34. Chan, E. D., Winston, B. W., Uh, S-T., Wynes, M. W., Rose, D. M., Riches, D. W. (1999) Evaluation of the role of mitogen-activated protein kinases in the expression of inducible nitric oxide synthase by IFN-γ and TNF-α in mouse macrophages. J. Immunol. 162, 415-422.
35. Riches, D. W., Chan, E. D., Zahradka, E. A., Winston, B. W., Remigio, L. K., Lake, F. R. (1998) Cooperative signaling by tumor necrosis factor receptors CD120a (p55) and CD120b (p75) in the expression of nitric oxide and inducible nitric oxide synthase by mouse macrophages. J. Biol. Chem. 273, 22800-22806.
36. Silkoff, P. E., Busacker, A., Trudeau, J., Jackson, M., Franklin, W. (2004) Sputum dysplasia, related to bacterial load, oxidative stress, and airway inflammation in COPD. Chest 125, 151S.
37. Silkoff, P. E., McClean, P. A., Slutsky, A. S., Furlott, H. G., Hoffstein, E., Wakita, S., Chapman, K. R., Szalai, J. P., Zamel, N. (1997) Marked flowdependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. Am. J. Resp. Crit. Care Med. 155, 260-267.
38. Miller, R. G. J. (1981) Simultaneous Statistical Inference. Springer-Verlag, New York, NY, USA.
39. Lowenstein, C. J., Alley, E. W., Raval, P., Snowman, A. M., Snyder, S. H. (1993) Macrophage nitric oxide synthase gene: two upstream regions Acad. Sci. USA 90, 9730-9734.
40. Xie, Q-W., Kashiwabara, Y., Nathan, C. F. (1994) Role of transcription factor NF-κ B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269, 4705-4708.
41. Churg, A., Dai, J., Zay, K., Karsan, A., Hendricks, R., Yee, C., Martin, R., MacKenzie, R., Xie, C., Zhang, L., Shapiro, S., Wright, J. L. (2001) α-1- Antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects. Lab. Invest. 81, 1119-1131.
42. Zhou, X., Shapiro, L., Fellingham, G., Willardson, B. M., Burton, G. F. (2011) HIV replication in CD4+ T lymphocytes in the presence and absence of follicular dendritic cells: inhibition of replication mediated by α-1-antitrypsin through altered IκBα ubiquitination. J. Immunol. 186, 3148-3155.
43. Karupiah, G., Xie, Q. W., Buller, R. M., Nathan, C., Duarte, C., Mac- Micking, J. D. (1993) Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science 261, 1445-1448.
44. Stamler, J. S. (1994) Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78, 931-936.
45. Kuhl, S. J., Rosen, H. (1998) Nitric oxide and septic shock: from bench to bedside. West. J. Med. 168, 176-181.
46. Wolkow, P. P. (1998) Involvement and dual effects of nitric oxide in septic shock. Inflamm. Res. 47, 152-166.
47. Crystal, R. G. (1990) α-1-Antitrypsin deficiency, emphysema, and liver disease. J. Clin. Invest. 85, 1343-1352.
48. Aktan, F. (2004) iNOS-mediated nitric oxide production and its regulation. Life Sci. 75, 639-653.
49. Chan, E. D., Riches, D. W. (2001) IFN-γ + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38(mapk) in a mouse macrophage cell line. Am. J. Physiol. Cell Physiol. 280, C441-C450.
50. Huang, H., Rose, J. L., Hoyt, D. G. (2004) p38 Mitogen-activated protein kinase mediates synergistic induction of inducible nitric-oxide synthase by lipopolysaccharide and interferon-γ through signal transducer and activator of transcription 1 Ser727 phosphorylation in murine aortic endothelial cells. Mol. Pharmacol. 66, 302-311.
51. Aldonyte, R., Hutchinson, T. E., Jin, B., Brantly, M., Block, E., Patel, J., Zhang, J. (2008) Endothelial α-1-antitrypsin attenuates cigarette smoke induced apoptosis in vitro. COPD 5, 153-162.
52. Petrache, I., Fijalkowska, I., Zhen, L., Medler, T. R., Brown, E., Cruz, P., Choe, K. H., Taraseviciene-Stewart, L., Scerbavicius, R., Shapiro, L., Zhang, B., Song, S., Hicklin, D., Voelkel, N. F., Flotte, T., Tuder, R. M. (2006) A novel antiapoptotic role for α1-antitrypsin in the prevention of pulmonary emphysema. Am. J. Respir. Crit. Care Med. 173, 1222-1228.
53. Lane, C., Knight, D., Burgess, S., Franklin, P., Horak, F., Legg, J., Moeller, A., Stick, S. (2004) Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath. Thorax 59, 757-760.
54. Dweik, R. A., Laskowski, D., Abu-Soud., H. M., Kaneko, F., Hutte, R., Stuehr, D. D., Erzurum, S. C. (1998) Nitric oxide synthesis in the lung. Regulation by oxygen through a kinetic mechanism. J. Clin. Invest. 101, 660-666.
55. Barnes, P. J., Dweik, R. A., Gelb, A. F., Gibson, P. G., George, S. C., Grasemann, H., Pavord, I. D., Ratjen, F., Silkoff, P. E., Taylor, D. R., Zamel, N. (2010) Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest 138, 682-692.
56. Stoller, J. K., Fromer, L., Brantly, M., Stocks, J., Strange, C. (2007) Primary care diagnosis of α-1 antitrypsin deficiency: issues and opportunities. Cleve. Clin. J. Med. 74, 869-874.
57. Machado, R. F., Stoller, J. K., Laskowski, D., Zheng, S., Lupica, J. A., Dweik, R. A., Erzurum, S. C. (2002) Low levels of nitric oxide and carbon monoxide in α 1-antitrypsin deficiency. J. Appl. Physiol. 93, 2038- 2043.
58. Malerba, M., Clini, E., Cremona, G., Radaeli, A., Bianchi, L., Corda, L., Pini, L., Ricciardolo, F., Grassi, V., Ambrosino, N. (2001) Exhaled nitric oxide in patients with PiZZ phenotype-related α 1-anti-trypsin deficiency. Respir. Med. 95, 520-525.
59. Jourd'heuil, D., Jourd'heuil, F. L., Kutchukian, P. S., Musah, R. A., Wink, D. A., Grisham, M. B. (2001) Reaction of superoxide and nitric oxide with peroxynitrite. Implications for peroxynitrite-mediated oxidation reactions in vivo. J. Biol. Chem. 276, 28799-28805.
60. Armstrong, R. (2001) The physiological role and pharmacological potential of nitric oxide in neutrophil activation. Int. Immunopharmacol. 1, 1501-1512.
61. Hazen, S. L., Zhang, R., Shen, Z., Wu, W., Podrez, E. A., MacPherson, J. C., Schmitt, D., Mitra, S. N., Mukhopadhyay, C., Chen, Y., Cohen, P. A., Hoff, H. F., Abu-Soud, H. M. (1999) Formation of nitric oxidederived oxidants by myeloperoxidase in monocytes: pathways for monocyte- mediated protein nitration and lipid peroxidation in vivo. Circ. Res. 85, 950-958.
62. Gompertz, S., Hill, A. T., Bayley, D. L., Stockley, R. A. (2006) Effect of expectoration on inflammation in induced sputum in α -1-antitrypsin deficiency. Respir. Med. 100, 1094-1099.
63. Hill, A. T., Bayley, D. L., Campbell, E. J., Hill, S. L., Stockley, R. A. (2000) Airways inflammation in chronic bronchitis: the effects of smoking and α 1-antitrypsin deficiency. Eur. Respir. J. 15, 886-890.
64. Spencer, L. T., Paone, G., Krein, P. M., Rouhani, F. N., Rivera-Nieves, J., Brantly, M. L. (2004) Role of human neutrophil peptides in lung inflammation associated with α 1-antitrypsin deficiency. Am. J. Physiol. Lung. Cell. Mol. Physiol. 286, L514-L520.
65. Malerba, M., Ragnoli, B., Radaeli, A. (2009) Exhaled nitric oxide levels in α -1-antitrypsin PiMZ subjects. J. Intern. Med. 265, 382-387.
66. Abboud, R. T., Ford, G. T., Chapman, K. R. (2001) α1-Antitrypsin deficiency: a position statement of the Canadian Thoracic Society. Can. Respir. J. 8, 81-88.
67. Weinberg, J. B., Misukonis, M. A., Shami, P. J., Mason, S. N., Sauls, D. L., Dittman, W. A., Wood, E. R., Smith, G. K., McDonald, B., Bachus, K. E. (1995) Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 86, 1184-1195.
68. Schneemann, M., Schoeden, G. (2007) Macrophage biology and immunology: man is not a mouse. J. Leukoc. Biol. 81, 579-580.
69. Stoller, J. K., Aboussouan, L. S. (2004) α 1-Antitrypsin deficiency. 5: intravenous augmentation therapy: current understanding. Thorax 59, 708-712